Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating difluprednate ophthalmic emulsion for severe uveitis and panuveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panuveitis
• Uveitis

Drugs mentioned

• Difluprednate ophthalmic emulsion (difluprednate)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Uveitis, Panuveitis | Phase 3 | Status: COMPLETED